This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013 Jul;13(7):568-569.

doi: 10.1016/S1473-3099(13)70101-4.

Rifampicin and moxifloxacin for tuberculous meningitis

Onno Akkerman¹, Arianna Pranger², Richard van Altena³, Tjip van der Werf³, Jan-Willem Alffenaar²

Affiliations

Affiliations

¹ Department of Pulmonology and Tuberculosis, University of Groningen, University Medical Center Groningen, Groningen, Netherlands. Electronic address: o.w.akkerman@umcg.nl.
² Department of Hospital and Clinical Pharmacy, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
³ Department of Pulmonology and Tuberculosis, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.

PMID: 23809221
DOI: 10.1016/S1473-3099(13)70101-4

Comment

Rifampicin and moxifloxacin for tuberculous meningitis

Onno Akkerman et al. Lancet Infect Dis. 2013 Jul.

. 2013 Jul;13(7):568-569.

doi: 10.1016/S1473-3099(13)70101-4.

Authors

Onno Akkerman¹, Arianna Pranger², Richard van Altena³, Tjip van der Werf³, Jan-Willem Alffenaar²

Affiliations

¹ Department of Pulmonology and Tuberculosis, University of Groningen, University Medical Center Groningen, Groningen, Netherlands. Electronic address: o.w.akkerman@umcg.nl.
² Department of Hospital and Clinical Pharmacy, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
³ Department of Pulmonology and Tuberculosis, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.

PMID: 23809221
DOI: 10.1016/S1473-3099(13)70101-4

No abstract available

PubMed Disclaimer

Comment in

Rifampicin and moxifloxacin for tuberculous meningitis--authors' reply.
Ruslami R, Ganiem AR, Aarnoutse RE, van Crevel R; study team. Ruslami R, et al. Lancet Infect Dis. 2013 Jul;13(7):570. doi: 10.1016/S1473-3099(13)70156-7. Lancet Infect Dis. 2013. PMID: 23809224 No abstract available.

Comment on

Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial.
Ruslami R, Ganiem AR, Dian S, Apriani L, Achmad TH, van der Ven AJ, Borm G, Aarnoutse RE, van Crevel R. Ruslami R, et al. Lancet Infect Dis. 2013 Jan;13(1):27-35. doi: 10.1016/S1473-3099(12)70264-5. Epub 2012 Oct 25. Lancet Infect Dis. 2013. PMID: 23103177 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations